Skip to content
10-Q

Quarterly Report

ENDOCYTE INC

0001558370-18-006046

← back to feed
Filed
Aug 1, 2018 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2018 · Jul 27, 2018 70.01M sh
Stock Repurchased Q2 2018 · Jun 30, 2018 $104.46K
Stock Repurchased Q2 2018 · Jun 30, 2017 $94.63K
Capex Q2 2018 · Jun 30, 2018 $14.71K
Capex Q2 2018 · Jun 30, 2017 $43.84K
Operating Cash Flow Q2 2018 · Jun 30, 2018 −$18.76M
Operating Cash Flow Q2 2018 · Jun 30, 2017 −$19.79M
Cash And Equivalents Q2 2018 · Jun 30, 2018 $25.04M
Cash And Equivalents Q2 2018 · Dec 31, 2017 $18.56M
Stockholders Equity Q2 2018 · Jun 30, 2018 $165.87M
Stockholders Equity Q2 2018 · Dec 31, 2017 $95.48M
Current Liabilities Q2 2018 · Jun 30, 2018 $5.95M
Current Liabilities Q2 2018 · Dec 31, 2017 $4.55M
Total Liabilities Q2 2018 · Jun 30, 2018 $6.3M
Total Liabilities Q2 2018 · Dec 31, 2017 $5.28M
Current Assets Q2 2018 · Jun 30, 2018 $168.56M
Current Assets Q2 2018 · Dec 31, 2017 $98.57M
Total Assets Q2 2018 · Jun 30, 2018 $172.17M
Total Assets Q2 2018 · Dec 31, 2017 $100.76M
Sga Expense Q2 2018 · Jun 30, 2018 $4.63M
Sga Expense Q2 2018 · Jun 30, 2018 $8.41M
Sga Expense Q2 2018 · Jun 30, 2017 $3.31M
Sga Expense Q2 2018 · Jun 30, 2017 $7.05M
Rd Expense Q2 2018 · Jun 30, 2018 $7.62M
Rd Expense Q2 2018 · Jun 30, 2018 $12.88M
Rd Expense Q2 2018 · Jun 30, 2017 $8.66M
Rd Expense Q2 2018 · Jun 30, 2017 $16.65M
Net Income Q2 2018 · Jun 30, 2018 −$11.56M
Net Income Q2 2018 · Jun 30, 2018 −$20.17M
Net Income Q2 2018 · Jun 30, 2017 −$11.74M
Net Income Q2 2018 · Jun 30, 2017 −$23.23M
Operating Income Q2 2018 · Jun 30, 2018 −$12.24M
Operating Income Q2 2018 · Jun 30, 2018 −$21.26M
Operating Income Q2 2018 · Jun 30, 2017 −$11.95M
Operating Income Q2 2018 · Jun 30, 2017 −$23.68M
Revenue Q2 2018 · Jun 30, 2018 $14.47K
Revenue Q2 2018 · Jun 30, 2018 $30.32K
Revenue Q2 2018 · Jun 30, 2017 $12.5K
Revenue Q2 2018 · Jun 30, 2017 $25K